Skip to content

OviTex® PRS P20263-1020GRecalls & reported problems

Tela Bio, Inc. · The OviTex® PRS Reinforced Tissue Matrix Device is a sterile reinforced matrix device comprised of non-dermal sourced layers of extracellular matrix (ECM) (ovine (sheep) derived ECM), paired with a minimal suture footprint. The OviTex PRS Reinforced Tissue Matrix Device provides an alternative device solution to permanent synthetic, resorbable/bioabsorbable synthetic, and biologic meshes. The device is permeable to facilitate fluid management, provides controlled stretch, and will incorporate into recipient tissue with associated cellular and microvascular ingrowth. Reinforced tissue matrices remodel into host tissue while maintaining compatibility with the body. The OviTex PRS Reinforced Tissue Matrix Device is for use in plastic and reconstructive surgery. · Class 2 · Implant

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
7
Deaths reported
0
Injuries reported
7
Recalls naming it
0

Summary

The FDA's MAUDE database contains 7 adverse event reports that list this exact device (DI 00810055070770), received between May 16, 2024 and Jul 25, 2025 — classified as 7 injuries.

The most frequently reported specific device problem is “Material Disintegration” (2 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 1 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 2 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 4 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520264
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem5
  • Material Disintegration2

Patient problems

  • Fluid Discharge6
  • Seroma1

Recent adverse event reports

The 7 most recent of 7 reports, in the reporter's own words as published by the FDA.

  • InjuryJul 25, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    IT WAS REPORTED THAT A PATIENT EXPERIENCED FLUID COLLECTION AND WOUND DRAINAGE APPROXIMATELY ONE MONTH AFTER A COSMETIC REVISION PROCEDURE PERFORMED WITH BREAST IMPLANTS AND OVITEX PRS. THE SURGEON PERFORMED A WASHOUT TO ADDRESS THE DRAINAGE ISSUE.

    Patient problems: Fluid Discharge

    MAUDE report 22609630 ↗
  • InjuryJul 25, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    IT WAS REPORTED THAT A PATIENT EXPERIENCED FLUID COLLECTION AND WOUND DRAINAGE APPROXIMATELY ONE MONTH AFTER A COSMETIC REVISION PROCEDURE PERFORMED WITH BREAST IMPLANTS AND OVITEX PRS. THE SURGEON PERFORMED A WASHOUT TO ADDRESS THE DRAINAGE ISSUE.

    Patient problems: Fluid Discharge

    MAUDE report 22609557 ↗
  • InjuryJul 25, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    IT WAS REPORTED THAT A PATIENT EXPERIENCED FLUID COLLECTION AND WOUND DRAINAGE APPROXIMATELY ONE MONTH AFTER A COSMETIC REVISION PROCEDURE PERFORMED WITH BREAST IMPLANTS AND OVITEX PRS. THE SURGEON PERFORMED A WASHOUT TO ADDRESS THE DRAINAGE ISSUE.

    Patient problems: Fluid Discharge

    MAUDE report 22609555 ↗
  • InjuryJul 25, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    IT WAS REPORTED THAT A PATIENT EXPERIENCED FLUID COLLECTION AND WOUND DRAINAGE APPROXIMATELY ONE MONTH AFTER A COSMETIC REVISION PROCEDURE PERFORMED WITH BREAST IMPLANTS AND OVITEX PRS. THE SURGEON PERFORMED A WASHOUT TO ADDRESS THE DRAINAGE ISSUE.

    Patient problems: Fluid Discharge

    MAUDE report 22609554 ↗
  • InjuryFeb 26, 2025Material Disintegration; Material Disintegration

    A PATIENT UNDERWENT BILATERAL MASTOPEXY WITH REVISION AUGMENTATION (BREAST IMPLANTS WERE APPROXIMATELY 20 YEARS OLD) ON (B)(6)2024. A PARTIAL CAPSULECTOMY WAS PERFORMED ANTERIORLY WITH MENTOR BOOST 480CC IMPLANTS AND OVITEX PRS LTR. ON (B)(6)2025 IT WAS NOTED THAT THE LEFT INCISION OPENED WITH OVITEX PRS PARTIALLY RESORBED WITH SOME POLYMER REMAINING. THE BREAST IMPLANT WAS REMOVED WITH THE NON-REMODELED OVITEX PRS. A SIMILAR EVENT OCCURRED AT THE RIGHT INCISION ON (B)(6)2025. PARTIAL OVITEX PRS INTEGRATION WAS NOTED ON BOTH SIDES.

    Patient problems: Fluid Discharge

    MAUDE report 21472954 ↗
  • InjuryFeb 26, 2025Material Disintegration; Material Disintegration

    A PATIENT UNDERWENT BILATERAL PRIMARY MASTOPEXY AUGMENTATION ON APPROXIMATELY (B)(6) 2024 WITH OVITEX PRS LTR USED AS LOWER POLE SUPPORT. THE PATIENT'S COURSE WAS UNREMARKABLE UNTIL 5 WEEKS POST-OP WHEN INCISIONS BROKE DOWN WITH IMPLANT EXPOSED. IT WAS NOTED THAT THE DEVICE WAS MOSTLY INCORPORATED SUPERIORLY BUT HAD RESORBED INFERIORLY. NON-INCORPORATED PORTIONS WERE REMOVED ALONG WITH THE BREAST IMPLANTS. THE PATIENT WAS LEFT TO HEAL PRIOR TO FINAL BREAST IMPLANT PLACEMENT.

    Patient problems: Fluid Discharge

    MAUDE report 21472837 ↗
  • InjuryMay 16, 2024Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    A PATIENT UNDERWENT BILATERAL PREPECTORAL TWO STAGE BREAST RECONSTRUCTION WITH TISSUE EXPANDERS AND OVITEX PRS. WITHIN APPROXIMATELY TWO WEEKS, ONE SIDE DEVELOPED A SEROMA. ON THE CONTRALATERAL SIDE DRAINAGE WAS NOTED THROUGH THE SURGICAL WOUND. THE SURGEON REMOVED BOTH TISSUE EXPANDERS AND OVITEX PRS DEVICES.

    Patient problems: Seroma

    MAUDE report 19330854 ↗

Other Mesh, Surgical devices

All Mesh, Surgical devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page